Abivax (ABVX) Selling, General & Administrative (2022 - 2026)

Abivax (ABVX) Selling, General & Administrative (2022 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -10.08 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 2.17 Mn
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 555.10 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 493.70 Mn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 647.70 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - 17.02 Mn
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -355.00 Mn
9 Revolution Medicines 37.37 Bn 37.37 Bn - 101.25 Mn
10 Abivax 9.98 Bn 9.98 Bn - -7.36 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -7.36 Mn
Dec 31, 2025 -30.15 Mn
Sep 30, 2025 -29.81 Mn
Jun 30, 2025 -9.36 Mn
Mar 31, 2025 -8.45 Mn
Dec 31, 2024 -8.11 Mn
Sep 30, 2024 -8.10 Mn
Jun 30, 2024 -10.55 Mn
Mar 31, 2024 -8.84 Mn
Dec 31, 2023 -24.10
Dec 31, 2022 -7.65